Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses.

T. Aoki,C. Hamada,S. Ohno,H. Miyakoshi,Y. Kaneko,M. Robert-Guroff,R. Ting,R. Gallo

DOI: https://doi.org/10.1007/978-3-642-70385-0_72

Abstract:

What problem does this paper attempt to address?

Degradation and adsorption of terbuthylazine and chlorpyrifos in biobed biomixtures from composted cotton crop residues.

Konstantina Kravvariti,N. Tsiropoulos,D. Karpouzas

DOI: https://doi.org/10.1002/ps.1990

IF: 4.462

2010-10-01

Pest Management Science

Abstract:BACKGROUND Biobeds have been well studied in northern Europe, whereas little is known regarding their use in southern Europe. The degradation and adsorption of terbuthylazine (TA) and chlorpyrifos (CP) were studied in three different biomixtures composed of composted cotton crop residues, soil and straw in various proportions, and also in sterilised and non-sterilised soil. RESULTS Compost biomixtures degraded the less hydrophobic TA at a faster rate than soil, while the opposite was evident for the more hydrophobic CP. These results were attributed to the rapid abiotic hydrolysis of CP in the alkaline soil (pH 8.5) compared with the lower pH of the compost (6.6), but also to the increasing adsorption (K(d) = 746 mL g(-1)) and reduced bioavailability of CP in the biomixtures compared with soil (K(d) = 17 mL g(-1)), as verified by the adsorption studies. CONCLUSIONS Compost had a dual but contrasting effect on degradation that depended on the chemical nature of the pesticide studied: a positive effect towards TA owing to increasing biodegradation and a negative effect towards CP owing to increasing adsorption. Overall, composted cotton crop residues could be potentially used in local biobed systems in Greece, as they promoted the degradation of hydrophilic pesticides and the adsorption of hydrophobic pesticides.
Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species

M Coakley,R P Ross,M Nordgren,G Fitzgerald,R Devery,C Stanton

DOI: https://doi.org/10.1046/j.1365-2672.2003.01814.x

Abstract:Aims: To assess strains of Lactobacillus, Lactococcus, Pediococcus and Bifidobacterium for their ability to produce the health-promoting fatty acid conjugated linoleic acid (CLA) from free linoleic acid. Methods and results: In this study, strains of Lactobacillus, Lactococcus, Pediococcus and Bifidobacterium were grown in medium containing free linoleic acid. Growth of the bacteria in linoleic acid and conversion of the linoleic acid to CLA was assessed. Of the bacteria assessed, nine strains of Bifidobacterium produced the c9, t11 CLA isomer from free linoleic acid. The t9, t11 CLA isomer was also produced by some strains, but at much lower concentrations. Conclusions: The production of CLA by bifidobacteria exhibited considerable interspecies variation. Bifidobacterium breve and B. dentium were the most efficient CLA producers among the range of strains tested, with B. breve converting up to 65% linoleic acid to c9, t11 CLA when grown in 0.55 mg ml(-1) linoleic acid. Strains also varied considerably with respect to their sensitivity to linoleic acid. Significance and impact of the study: The production of CLA by probiotic bifidobacteria offers a possible mechanism for some health-enhancing properties of bifidobacteria and provides novel opportunities for the development of functional foods.
Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism

Ahmad Ud Din,Adil Hassan,Yuan Zhu,Kun Zhang,Yi Wang,Tianhan Li,Yang Wang,Guixue Wang

DOI: https://doi.org/10.1016/j.jnutbio.2020.108353

Abstract:Probiotics are known to be beneficial in preventing different diseases in model animals, including inflammatory bowel disease. However, there are few studies on probiotics related to miRNA regulation and disease status. In this article, the beneficial role and mechanisms of the probiotic strain Bifidobacterium bifidum ATCC 29521 have been studied in ulcerative colitis using dextran sodium sulphate (DSS) model. Male C57JBL/6 mice were randomly divided into three groups (n=7): Normal group, dextran sulphate sodium (DSS) group, and Bifido group gavage with Bifidobacterium bifidum ATCC 29521 (2×108 CFU/day). Our strain restored the DSS-caused damage by regulating the expression of immune markers and tight junction proteins (TJP) in the colon; briefly by up-regulating ROS-scavenging enzymes (SOD1, SOD2, CAT, and GPX2), anti-inflammatory cytokines (IL-10, PPARγ, IL-6), TJP's (ZO-1, MUC-2, Claudin-3, and E Cadherin-1) and downregulating inflammatory genes (TNF-α, IL-1β) in Bifido group mice. Inflammatory markers appeared to be regulated by NF-κB nuclear P65 subunit, and its translocation was inhibited in Bifido group mice colon. In addition, the expression of inflammatory genes and colonic TJP were also associated with the restoration of miRNAs (miR-150, miR-155, miR-223) in B. bifidum ATCC 29521 treated Bifido group. The dysbiosis executed by DSS was restored in the Bifido group, demonstrating that B. bifidum ATCC 29521 possessed a probiotic role in our DSS colitis mouse model. B. bifidum ATCC 29521 exhibited its probiotic role through its anti-inflammatory role by modulating miRNA-associated TJP and NF-κB regulation and by partially restoring dysbiosis.
Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Rafael Tojo

DOI: https://doi.org/10.3748/wjg.v20.i41.15163

IF: 5.374

2014-01-01

World Journal of Gastroenterology

Abstract:The pool of microbes inhabiting our body is known as "microbiota" and their collective genomes as "microbiome". The colon is the most densely populated organ in the human body, although other parts, such as the skin, vaginal mucosa, or respiratory tract, also harbour specific microbiota. This microbial community regulates some important metabolic and physiological functions of the host, and drives the maturation of the immune system in early life, contributing to its homeostasis during life. Alterations of the intestinal microbiota can occur by changes in composition (dysbiosis), function, or microbiota-host interactions and they can be directly correlated with several diseases. The only disease in which a clear causal role of a dysbiotic microbiota has been demonstrated is the case of Clostridium difficile infections. Nonetheless, alterations in composition and function of the microbiota have been associated with several gastrointestinal diseases (inflammatory bowel disease, colorectal cancer, or irritable bowel syndrome), as well as extra-intestinal pathologies, such as those affecting the liver, or the respiratory tract (e.g., allergy, bronchial asthma, and cystic fibrosis), among others. Species of Bifidobacterium genus are the normal inhabitants of a healthy human gut and alterations in number and composition of their populations is one of the most frequent features present in these diseases. The use of probiotics, including bifidobacteria strains, in preventive medicine to maintain a healthy intestinal function is well documented. Probiotics are also proposed as therapeutic agents for gastrointestinal disorders and other pathologies. The World Gastroenterology Organization recently published potential clinical applications for several probiotic formulations, in which species of lactobacilli are predominant. This review is focused on probiotic preparations containing Bifidobacterium strains, alone or in combination with other bacteria, which have been tested in human clinical studies. In spite of extensive literature on and research into this topic, the degree of scientific evidence of the effectiveness of probiotics is still insufficient in most cases. More effort need to be made to design and conduct accurate human studies demonstrating the efficacy of probiotics in the prevention, alleviation, or treatment of different pathologies.

gastroenterology & hepatology
Serologic and skin test evidence of tularemia infection among Alaskan Eskimos, Indians and Aleuts.

R. Philip,Bob Huntley,Lackman Db,George W. Comstock

DOI: https://doi.org/10.1093/INFDIS/110.3.220

1962-05-01

Abstract:Health Nurses, including Mrs. Thomas Haley, Mrs. Elaine Clement, and the Misses Mildred Walter, Lovina Woodrow, Elizabeth Van Creveld and Inez Monaghan, whose itinerant nursing activities in remote Alaska villages made this study possible. The contributions of the Alaskan Division of Health, particularly those of Mr. Ralph B. Williams and Mr. Frank P. Pauls, are appreciated. The authors would also like to thank Dr. Karl R. Reinhard for help in obtaining blood samples, Mr. Raymond Thrailkill for his technical assistance, and Mrs. Phillip Judd for her statistical clerical help. * U. S. Public Health Service, National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratory, Hamilton, Montana. t U. S. Public Health Service, Communicable Disease Center, Tuberculosis Program, Washington 25, D. C. mia in a man from Northway in central Alaska who had trapped muskrats shortly prior to illness. Subsequently, at least 3 other cases were identified and
Computational Analysis and Heterologous Expression of BBI-like Proteins from Food-Grade Bifidobacterium Species Reveal Possibly a Key Factor in Conjugated Linoleic Acid Bioconversion

Yongchao Mei,Haiqin Chen,Bo Yang,Jianxin Zhao,Hao Zhang,Wei Chen

DOI: https://doi.org/10.1021/acs.jafc.3c00857

2023-05-31

Abstract:Bifidobacteria are well-known probiotics that can produce multiple health-promoting bioactivities, including the bioconversion of conjugated linoleic acid (CLA). However, there is a lack of insights into the genetic diversity of functional proteins in Bifidobacterium at the species level, particularly owing to the vastly different CLA conversion capabilities of these strains. Here, we performed a comprehensive bioinformatics analysis and the in vitro expression of bbi-like sequences that are widely distributed among CLA-producing Bifidobacterium strains. The BBI-like protein sequences from all four species of bifidobacterial CLA-producing strains were predicted to be stable integral membrane proteins with a transmembrane topology number of seven or nine. All BBI-like proteins were found to be expressed in the Escherichia coli BL21(DE3) hosts with a pure c9, t11-CLA-producing activity. Furthermore, their activities significantly differed in the same genetic background, and their sequence differences were indicated to be important potential factors contributing to the high activity levels in CLA-producing Bifidobacterium breve strains. The use of microorganisms, such as food-grade or industrial-grade strains, to obtain single CLA isomers will accelerate CLA-related food and nutrition research and further enrich the scientific theory of bifidobacteria as probiotics.
Microbial metabolites as modulators of host physiology

Susan A. Joyce,David J. Clarke

DOI: https://doi.org/10.1016/bs.ampbs.2023.12.001

2024-01-18

Advances in Microbial Physiology

Abstract:The gut microbiota is increasingly recognised as a key player in influencing human health and changes in the gut microbiota have been strongly linked with many non-communicable conditions in humans such as type 2 diabetes, obesity and cardiovascular disease. However, characterising the molecular mechanisms that underpin these associations remains an important challenge for researchers. The gut microbiota is a complex microbial community that acts as a metabolic interface to transform ingested food (and other xenobiotics) into metabolites that are detected in the host faeces, urine and blood. Many of these metabolites are only produced by microbes and there is accumulating evidence to suggest that these microbe-specific metabolites do act as effectors to influence human physiology. For example, the gut microbiota can digest dietary complex polysaccharides (such as fibre) into short-chain fatty acids (SCFA) such as acetate, propionate and butyrate that have a pervasive role in host physiology from nutrition to immune function. In this review we will outline our current understanding of the role of some key microbial metabolites, such as SCFA, indole and bile acids, in human health. Whilst many studies linking microbial metabolites with human health are correlative we will try to highlight examples where genetic evidence is available to support a specific role for a microbial metabolite in host health and well-being.

microbiology,biochemistry & molecular biology
Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria

Jean Guy LeBlanc,Florian Chain,Rebeca Martín,Luis G. Bermúdez-Humarán,Stéphanie Courau,Philippe Langella

DOI: https://doi.org/10.1186/s12934-017-0691-z

IF: 6.352

2017-05-08

Microbial Cell Factories

Abstract:The aim of this review is to summarize the effect in host energy metabolism of the production of B group vitamins and short chain fatty acids (SCFA) by commensal, food-grade and probiotic bacteria, which are also actors of the mammalian nutrition. The mechanisms of how these microbial end products, produced by these bacterial strains, act on energy metabolism will be discussed. We will show that these vitamins and SCFA producing bacteria could be used as tools to recover energy intakes by either optimizing ATP production from foods or by the fermentation of certain fibers in the gastrointestinal tract (GIT). Original data are also presented in this work where SCFA (acetate, butyrate and propionate) and B group vitamins (riboflavin, folate and thiamine) production was determined for selected probiotic bacteria.

biotechnology & applied microbiology
The role of the physical embodiment of a music therapist robot for individuals with cognitive impairments: Longitudinal study

A. Tapus

DOI: https://doi.org/10.1109/ICVR.2009.5174241

2009-07-24

Abstract:The world population is growing older. Global aging is occurring at a rate never seen before, it is expected that in 2040 there will be three times more people over the age 85 than there are today. Even if nursing homes and other care facilities can provide assistance, space and staff shortages are already becoming an issue. One of the aims of this work is to show the benefits of robot's physical embodiment in human-robot social interactions. The social therapist robot tries to provide customized cognitive stimulation by playing a music game with the participant. The results of the pilot study over a 6 month period depict a more efficient, natural, and preferred interaction with the robot rather than with the simulated robot.
Lactobacilli and Bifidobacteria: A Parapostbiotic Approach to Study and Explain Their Mutual Bioactive Influence

Clelia Altieri,Alfonso Filippone,Antonio Bevilacqua,Maria Rosaria Corbo,Milena Sinigaglia

DOI: https://doi.org/10.3390/foods13182966

IF: 5.2

2024-09-19

Foods

Abstract:Three strains of Lactiplantibacillus plantarum and three bifidobacteria (Bifidobacterium animalis subsp. lactis, Bifidobacterium breve, and Bifidobacterium subtile) were used as target strains; in addition, for each microorganism, the cell-free supernatant (CFS) was produced and used as an ingredient of the growth medium. Namely CFSs from lactobacilli were used on bifidobacteria and CFSs from bifidobacteria were used on lactobacilli. The viable count was assessed, and the data were modelled through a reparametrized Gompertz equation cast both in the positive and negative form to evaluate the parameters t-7log, which is the time after which the viable count was 7 log CFU/mL, and the t-7log*, which is the time after which the viable count was below 7 log CFU/mL; the difference between the t-7log* and t-7log defines the stability time. Statistics through a multiparametric ANOVA (analysis of variance) provided evidence for the presence of a bifidogenic and/or bioactive factor produced by bifidobacteria and active on lactobacilli, and vice versa (bioactive factor of lactobacilli with a functional effect on bifidobacteria), although further studies are required to better explain the mechanisms beyond the positive effects. In addition, the influence on the target strains can be found during the growth phase (stimulation), as well as during senescence and death phase (protective effect), with a strong strain/species dependence on both CFS production and target strain.
Gut Bifidobacteria Populations in Human Health and Aging

Silvia Arboleya,Claire Watkins,Catherine Stanton,R. Paul Ross

DOI: https://doi.org/10.3389/fmicb.2016.01204

IF: 5.2

2016-08-19

Frontiers in Microbiology

Abstract:The intestinal microbiota has increasingly been shown to have a vital role in various aspects of human health. Indeed, several studies have linked alterations in the gut microbiota with the development of different diseases. Among the vast gut bacterial community, Bifidobacterium is a genus which dominates the intestine of healthy breast-fed infants whereas in adulthood the levels are lower but relatively stable. The presence of different species of bifidobacteria changes with age, from childhood to old age. Bifidobacterium longum, B. breve, and B. bifidum are generally dominant in infants, whereas B. catenulatum, B. adolescentis and, as well as B. longum are more prevalent in adults. Increasingly, evidence is accumulating which shows beneficial effects of supplementation with bifidobacteria for the improvement of human health conditions ranging from protection against infection to different extra- and intra-intestinal positive effects. Moreover, bifidobacteria have been associated with the production of a number of potentially health promoting metabolites including short chain fatty acids, conjugated linoleic acid and bacteriocins. The aim of this mini-review is to describe the bifidobacteria compositional changes associated with different stages in life, highlighting their beneficial role, as well as their presence or absence in many disease states.

microbiology
Short-Chain Fatty Acids Modulate Healthy Gut Microbiota Composition and Functional Potential

Christine Tara Peterson,Josue Perez Santiago,Stanislav N. Iablokov,Deepak Chopra,Dmitry A. Rodionov,Scott N. Peterson

DOI: https://doi.org/10.1007/s00284-022-02825-5

IF: 2.343

2022-03-14

Current Microbiology

Abstract:Abstract Many studies have focused on the metabolic capacity of human gut microbiota to produce short-chain fatty acids and subsequent effects on host physiology. Given scarce data on how SCFAs produced by gut bacteria participate in cross-feeding to influence community structure and function, we evaluated the potential of SCFAs to modulate human gut microbiota in vitro. We employed anaerobic fecal cultivation in chemically defined medium supplemented with one of nine SCFAs to determine effects on both gut microbial community structure via 16S rRNA sequencing and function via genome reconstruction analysis. Each SCFA displayed significant and unique modulatory potential with respect to the relative abundance of bacterial taxa. Analysis of SCFA-supplemented communities revealed that alterations of individual closely related phylotypes displayed coherent changes, although exceptions were also observed which suggest strain-dependent differences in SCFA-induced changes. We used genome reconstruction to evaluate the functional implications of SCFA-mediated restructuring of fecal communities. We note that some SCFA-supplemented cultures displayed a reduction in the predicted abundance of SCFA producers, which suggests a possible undefined negative feedback mechanism. We conclude that SCFAs are not simply end-products of metabolism but also serve to modulate the gut microbiota through cross-feeding that alters the fitness of specified taxa. These results are important in the identification of prebiotics that elevate specific SCFAs for therapeutic benefit and highlight SCFA consumers as a salient part of the overall metabolic flux pertaining to bacterial fermentative processes.

microbiology
The metabolites of lactic acid bacteria: classification, biosynthesis and modulation of gut microbiota

Huang Tang,Wanqiu Huang,Yu-Feng Yao

DOI: https://doi.org/10.15698/mic2023.03.792

2023-03-06

Microbial Cell

Abstract:Lactic acid bacteria (LAB) are ubiquitous microorganisms that can colonize the intestine and participate in the phys-iological metabolism of the host. LAB can produce a variety of metabolites, including organic acids, bacteriocin, amino acids, exopolysaccharides and vitamins. These metabolites are the basis of LAB function and have a profound impact on host health. The intestine is colonized by a large num-ber of gut microorganisms with high species diversity. Me-tabolites of LAB can keep the balance and stability of gut microbiota through aiding in the maintenance of the intes-tinal epithelial barrier, resisting to pathogens and regulat-ing immune responses, which further influence the nutri-tion, metabolism and behavior of the host. In this review, we summarize the metabolites of LAB and their influence on the intestine. We also discuss the underlying regulatory mechanisms and emphasize the link between LAB and the human gut from the perspective of health promotion.
Identifying TV Channels & On-Demand Videos using Ambient Light Sensors

Lorenz Schwittmann,Christopher Boelmann,V. Matkovic,Matthäus Wander,Torben Weis

DOI: https://doi.org/10.1016/j.pmcj.2016.08.018

IF: 3.848

2017-07-01

Pervasive and Mobile Computing

Abstract:
Postbiotic impact on host metabolism and immunity provides therapeutic potential in metabolic disease

Han Fang,Rodrigo Rodrigues E-Lacerda,Nicole G Barra,Dana Kukje Zada,Nazli Robin,Alina Mehra,Jonathan D Schertzer

DOI: https://doi.org/10.1210/endrev/bnae025

2024-09-05

Abstract:The gut microbiota influences aspects of metabolic disease, including tissue inflammation, adiposity, blood glucose, insulin, and endocrine control of metabolism. Prebiotics or probiotics are often sought to combat metabolic disease. However, prebiotics lack specificity and can have deleterious bacterial community effects. Probiotics require live bacteria to find a colonization niche sufficient to influence host immunity or metabolism. Postbiotics encompass bacterial-derived components and molecules, which are well-positioned to alter host immunometabolism without relying on colonization efficiency or causing widespread effects on the existing microbiota. Here, we summarize the potential for beneficial and detrimental effects of specific postbiotics related to metabolic disease and the underlying mechanisms of action. Bacterial cell wall components such as lipopolysaccharides, muropeptides, lipoteichoic acids and flagellin have context-dependent effects on host metabolism by engaging specific immune responses. Specific types of postbiotics within broad classes of compounds such as lipopolysaccharides, muropeptides can have opposing effects on endocrine control of host metabolism where certain postbiotics are insulin sensitizers and others promote insulin resistance. Bacterial metabolites such as short chain fatty acids, bile acids, lactate, glycerol, succinate, ethanolamine, and ethanol can be substrates for host metabolism. Postbiotics can fuel host metabolic pathways directly or influence endocrine control of metabolism through immunomodulation or mimicking host-derived hormones. The interaction of postbiotics in the host-microbe relationship should be considered during metabolic inflammation and metabolic disease.
Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains

Sabine Bosselaar,Lucile Dhelin,Ellena Dautel,Marie Titecat,Stéphanie Duthoy,Marie Stelmaszczyk,Nathan Delory,Madeleine De Sousa Violante,François Machuron,Hassina Ait-Abderrahim,Pierre Desreumaux,Benoit Foligné,Céline Monnet

DOI: https://doi.org/10.1186/s12866-024-03368-4

IF: 4.465

2024-06-29

BMC Microbiology

Abstract:Abstract Background Inflammatory Bowel Diseases (IBD) are a major public health issue with unclear aetiology. Changes in the composition and functionality of the intestinal microbiota are associated with these pathologies, including the depletion of strict anaerobes such as Feacalibacterium prausnitzii . Less evidence is observed for depletion in other anaerobes, among which bifidobacteria. This study characterized the taxonomic and functional diversity of bifidobacteria isolated from the human intestinal microbiota in active and non-active IBD patients by a culturomics approach and evaluated if these bifidobacteria might be used as probiotics for gut health. Results A total of 341 bifidobacteria were isolated from the intestinal microbiota of IBD patients (52 Crohn’s disease and 26 ulcerative colitis patients), with a high proportion of Bifidobacterium dentium strains (28% of isolated bifidobacteria). In ulcerative colitis, the major species identified was B. dentium (39% of isolated bifidobacteria), in active and non-active ulcerative colitis. In Crohn’s disease, B. adolescentis was the major species isolated from non-active patients (40%), while similar amounts of B. dentium and B. adolescentis were found in active Crohn’s disease patients. The relative abundance of B. dentium was increased with age, both in Crohn’s disease and ulcerative colitis and active and non-active IBD patients. Antibacterial capacities of bifidobacteria isolated from non-active ulcerative colitis against Escherichia coli LF82 and Salmonella enterica ATCC 14028 were observed more often compared to strains isolated from active ulcerative colitis. Finally, B. longum were retained as strains with the highest probiotic potential as they were the major strains presenting exopolysaccharide synthesis, antibacterial activity, and anti-inflammatory capacities. Antimicrobial activity and EPS synthesis were further correlated to the presence of antimicrobial and EPS gene clusters by in silico analysis. Conclusions Different bifidobacterial taxonomic profiles were identified in the microbiota of IBD patients. The most abundant species were B. dentium , mainly associated to the microbiota of ulcerative colitis patients and B. adolescentis , in the intestinal microbiota of Crohn’s disease patients. Additionally, the relative abundance of B. dentium significantly increased with age. Furthermore, this study evidenced that bifidobacteria with probiotic potential (antipathogenic activity, exopolysaccharide production and anti-inflammatory activity), especially B. longum strains, can be isolated from the intestinal microbiota of both active and non-active Crohn’s disease and ulcerative colitis patients.

microbiology
Conjugated Linoleic Acid Supplementation under a High-Fat Diet Modulates Stomach Protein Expression and Intestinal Microbiota in Adult Mice

Alice Chaplin,Pilar Parra,Francisca Serra,Andreu Palou

DOI: https://doi.org/10.1371/journal.pone.0125091

IF: 3.7

2015-04-27

PLoS ONE

Abstract:The gastrointestinal tract constitutes a physiological interface integrating nutrient and microbiota-host metabolism. Conjugated linoleic acids (CLA) have been reported to contribute to decreased body weight and fat accretion. The modulation by dietary CLA of stomach proteins related to energy homeostasis or microbiota may be involved, although this has not been previously analysed. This is examined in the present study, which aims to underline the potential mechanisms of CLA which contribute to body weight regulation. Adult mice were fed either a normal fat (NF, 12% kJ content as fat) or a high-fat (HF, 43% kJ content as fat) diet. In the latter case, half of the animals received daily oral supplementation of CLA. Expression and content of stomach proteins and specific bacterial populations from caecum were analysed. CLA supplementation was associated with an increase in stomach protein expression, and exerted a prebiotic action on both Bacteroidetes/Prevotella and Akkermansia muciniphila. However, CLA supplementation was not able to override the negative effects of HF diet on Bifidobacterium spp., which was decreased in both HF and HF+CLA groups. Our data show that CLA are able to modulate stomach protein expression and exert a prebiotic effect on specific gut bacterial species.

multidisciplinary sciences
Structure, expression, and chromosomal localization of human GAK.

S. H. Kimura,H. Tsuruga,N. Yabuta,Yuichi Endo,Hiroshi Nojima

DOI: https://doi.org/10.1006/GENO.1997.4873

IF: 4.31

1997-09-01

Genomics

Abstract:We previously cloned a rat cDNA encoding GAK, an association partner of cyclin G and CDK5. Here, we report the cloning of a cDNA encoding human GAK (1311 amino acids) and show that all of the unique motifs that characterize rat GAK, such as the presence of a Ser/Thr kinase domain, a tensin/auxilin homologous domain, and a Tyr phosphorylation target site, are conserved. The expression profiles of GAK and cyclin G during the synchronized HeLa cell cycle showed that GAK expression oscillates slightly, peaking at G1 phase, although the histone H1 kinase activity remains constant throughout the cell cycle. We also found that the kinase activity of immunoprecipitates of anti-cyclin G antibody fluctuates during the cell cycle with a peak at G1 phase, although the expression level of cyclin G remains almost constant. Northern blot analysis showed that GAK is expressed ubiquitously, with the highest level of expression being observed in the testis. By the FISH technique, we assigned the chromosomal localization of GAK to 4p16.
Bifidobacterium mechanisms of immune modulation and tolerance

Samuel J Gavzy,Allison Kensiski,Zachariah L Lee,Emmanuel F Mongodin,Bing Ma,Jonathan S Bromberg

DOI: https://doi.org/10.1080/19490976.2023.2291164

IF: 12.2

2023-12-06

Gut Microbes

Abstract:Bifidobacterium is a widely distributed commensal bacterial genus that displays beneficial pro-homeostatic and anti-inflammatory immunomodulatory properties. Depletion or absence of Bifidobacterium in humans and model organisms is associated with autoimmune responses and impaired immune homeostasis. At the cellular level, Bifidobacterium upregulates suppressive regulatory T cells, maintains intestinal barrier function, modulates dendritic cell and macrophage activity, and dampens intestinal Th2 and Th17 programs. While there has been a large volume of literature characterizing the probiotic properties of various Bifidobacterial species, the likely multifactorial mechanisms underlying these effects remain elusive, in particular, its immune tolerogenic effect. However, recent work has shed light on Bifidobacterium surface structural polysaccharide and protein elements, as well as its metabolic products, as commensal mediators of immune homeostasis. This review aims to discuss several mechanisms Bifidobacterium utilizes for immune modulation as well as their indirect impact on the regulation of gut microbiome structure and function, from structural molecules to produced metabolites. These mechanisms are pertinent to an increasingly networked understanding of immune tolerance and homeostasis in health and disease.

gastroenterology & hepatology,microbiology
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites

Ara Koh,Filipe De Vadder,Petia Kovatcheva-Datchary,Fredrik Bäckhed

DOI: https://doi.org/10.1016/j.cell.2016.05.041

IF: 64.5

2016-06-01

Cell

Abstract:A compelling set of links between the composition of the gut microbiota, the host diet, and host physiology has emerged. Do these links reflect cause-and-effect relationships, and what might be their mechanistic basis? A growing body of work implicates microbially produced metabolites as crucial executors of diet-based microbial influence on the host. Here, we will review data supporting the diverse functional roles carried out by a major class of bacterial metabolites, the short-chain fatty acids (SCFAs). SCFAs can directly activate G-coupled-receptors, inhibit histone deacetylases, and serve as energy substrates. They thus affect various physiological processes and may contribute to health and disease.

cell biology,biochemistry & molecular biology

Roles of HTLV-I p19 and natural antibody to HTLV-I in host immune responses.

Degradation and adsorption of terbuthylazine and chlorpyrifos in biobed biomixtures from composted cotton crop residues.

Conjugated linoleic acid biosynthesis by human-derived Bifidobacterium species

Inhibitory effect of Bifidobacterium bifidum ATCC 29521 on colitis and its mechanism

Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis

Serologic and skin test evidence of tularemia infection among Alaskan Eskimos, Indians and Aleuts.

Computational Analysis and Heterologous Expression of BBI-like Proteins from Food-Grade Bifidobacterium Species Reveal Possibly a Key Factor in Conjugated Linoleic Acid Bioconversion

Microbial metabolites as modulators of host physiology

Beneficial effects on host energy metabolism of short-chain fatty acids and vitamins produced by commensal and probiotic bacteria

The role of the physical embodiment of a music therapist robot for individuals with cognitive impairments: Longitudinal study

Lactobacilli and Bifidobacteria: A Parapostbiotic Approach to Study and Explain Their Mutual Bioactive Influence

Gut Bifidobacteria Populations in Human Health and Aging

Short-Chain Fatty Acids Modulate Healthy Gut Microbiota Composition and Functional Potential

The metabolites of lactic acid bacteria: classification, biosynthesis and modulation of gut microbiota

Identifying TV Channels & On-Demand Videos using Ambient Light Sensors

Postbiotic impact on host metabolism and immunity provides therapeutic potential in metabolic disease

Taxonomic and phenotypic analysis of bifidobacteria isolated from IBD patients as potential probiotic strains

Conjugated Linoleic Acid Supplementation under a High-Fat Diet Modulates Stomach Protein Expression and Intestinal Microbiota in Adult Mice

Structure, expression, and chromosomal localization of human GAK.

Bifidobacterium mechanisms of immune modulation and tolerance

From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites